Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-09Clinical Trial Update: L9LS-R21 Interaction [Phase 2]
A Phase 2 clinical trial evaluating L9LS-R21 for malaria has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-14Clinical Trial Update: MaCRA Part B in Côte d'Ivoire [NA]
A PATH-sponsored MaCRA Part B trial in Côte d'Ivoire for malaria has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-14Clinical Trial Update: MaCRA Part B in Nigeria [NA]
The MaCRA Part B malaria trial in Nigeria, sponsored by PATH, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-07Clinical Trial Update: Spatial Repellents for Malaria Control [NA]
A clinical trial evaluating spatial repellents for malaria control (NCT06122142) sponsored by the University of Notre Dame has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2023-05-11Clinical Trial Update: Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia [Phase 2, Phase 3]
A phase 2/3 trial evaluating a double-dose primaquine regimen for radical cure of Plasmodium vivax in Colombia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-07-05Clinical Trial Update: Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine [Phase 1]
A Phase 1 trial assessing the safety and immunogenicity of a Pfs25-Pfs25 conjugate malaria vaccine has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-29Clinical Trial Update: Leiden University Medical Center Mini Donor Bank
Leiden University Medical Center's Mini Donor Bank trial (NCT02810613) has been withdrawn; the listed conditions include malaria, Schistosom…
-
CLINICAL_TRIALS withdrawal · 2017-02-08Clinical Trial Update: A Trial on Supervised Primaquine Use in Ethiopia [Phase 4]
A Phase 4 trial evaluating supervised primaquine use for malaria in Ethiopia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-06Clinical Trial Update: Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM) [NA]
A malaria-focused clinical trial in Zambia evaluating spatial repellent products has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-06Clinical Trial Update: Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya [NA]
A clinical trial evaluating spatial repellent products for malaria prevention in Kenya has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2016-10-06Clinical Trial Update: Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania [NA]
A clinical trial evaluating spatial repellent products for malaria control in Tanzania has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-13Clinical Trial Update: Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly [Phase 3]
A Phase 3 clinical trial evaluating prednisone plus chloroquine for hyper-reactive malarial splenomegaly has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-30Clinical Trial Update: A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents [Phase 1]
A Phase 1 clinical trial of the NMRC-M3V-Ad-PfCA vaccine in healthy adults for malaria has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-22Clinical Trial Update: Prevention of P. Vivax Malaria During Pregnancy in Bolivia [Phase 4]
This Phase 4 trial evaluating prevention of Plasmodium vivax malaria during pregnancy in Bolivia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-30Clinical Trial Update: Efficacy of Artesunate-amodiaquine (AS-AQ) in Children With Malaria and Severe Acute Malnutrition, Madaoua, Niger 2010 [Phase 4]
Phase 4 trial evaluating artesunate-amodiaquine in children with falciparum malaria and severe acute malnutrition in Niger has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2012-04-13Clinical Trial Update: Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection [Phase 2, Phase 3]
Clinical trial investigating the pharmacokinetics of the mefloquine-artesunate combination in pregnant women with uncomplicated Plasmodium f…
-
CLINICAL_TRIALS withdrawal · 2011-09-27Clinical Trial Update: Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate [Phase 2]
A Phase 2 trial evaluating fosmidomycin with clindamycin, with or without artesunate, for malaria has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-07-07Clinical Trial Update: A Randomized Controlled Trial for Intermittent Preventive Treatment in Pregnancy With Fansidar in Solomon Islands [Phase 4]
A Phase 4 randomized trial of intermittent preventive treatment in pregnancy with Fansidar (sulfadoxine-pyrimethamine) in Solomon Islands ha…